Government Taxation, Spending, and Debt
Humana’s planned Medicare Advantage exits show why a plan nonrenewal can require urgent consumer decisions without ending a person’s Medicare eligibility.
What to Know
- Humana expects selected Medicare Advantage plan exits to affect about 600,000 members in 2027.
- A plan’s nonrenewal does not cancel a person’s Medicare Part A or Part B eligibility.
- Medicare’s annual enrollment period runs from October 15 through December 7.
- A replacement plan may have different doctors, hospitals, pharmacies, drug coverage, premiums, and out-of-pocket costs.
- Federal policy sets Medicare Advantage payment rules, but higher payments do not guarantee that every plan will remain available.
During Humana’s July 29, 2026 earnings call, Chief Financial Officer Celeste Mellet said targeted Medicare Advantage plan exits for 2027 would affect about 600,000 members. Humana’s official earnings-call transcript records the statement.
For an affected senior, however, the news is not only a corporate strategy decision. It can mean comparing new coverage, confirming that trusted doctors remain available, and checking whether prescriptions will still be covered at an affordable pharmacy. The central question is simple: what changes when a Medicare Advantage plan disappears, and what does not?
A Plan Can End Without Ending Medicare
Medicare Advantage is a private-plan option through which people receive their Medicare benefits. To enroll, a person must have Medicare Part A and Part B, live in the plan’s service area, and enroll during a valid election period, according to CMS enrollment guidance.
That distinction matters. If a Medicare Advantage plan does not renew in a beneficiary’s area, the person does not lose Medicare itself. They can select another Medicare Advantage plan, or they can return to Original Medicare. Original Medicare includes Part A and Part B, but it does not automatically include prescription-drug coverage. People who choose it can add a separate Part D drug plan, as Medicare.gov explains.
CMS guidance provides a Special Enrollment Period for people whose plan or contract terminates. If a person does not choose a new Medicare Advantage plan before the termination date, CMS generally returns that person to Original Medicare, while the enrollment opportunity continues for two months after termination. That rule prevents a plan exit from becoming a loss of basic Medicare eligibility, but it does not remove the need to make an informed coverage choice.
CMS explains annual Medicare Advantage enrollment choices.
The reason a plan disappears is a business decision by an insurer. That decision, in turn, reflects how Medicare Advantage payments, medical costs, and plan design interact.
Why Insurers Pull Back
Humana’s management said its 2027 exits would target the lower end of the company’s profitability and return profile rather than reduce plans evenly across its portfolio. The company said it would seek to retain affected members in its remaining offerings while protecting plans it considers higher value.
During its July 29, 2026 earnings call, Humana said it expected to recapture a similar portion of affected members as it did after its 2025 plan exits. In the call’s Q&A, Chief Financial Officer Celeste Mellet said that prior recapture rate was just over 40%. Humana’s official earnings-call transcript records both the 600,000-member estimate and the recapture expectation.
CMS’s 2027 Medicare Advantage payment-change table.
Medicare Advantage insurers receive federal payments to provide Part A and Part B benefits, and many plans also include Part D drug coverage and additional benefits. Companies must balance those payments against the cost of medical care, prescription drugs, provider contracts, administration, and benefit packages.
CMS finalized a net average 2.48% increase in Medicare Advantage payments for 2027, equal to more than $13 billion in additional payments across the program. The CMS 2027 Rate Announcement also shows that payment changes include several components, such as growth rates, risk adjustment, and quality-related factors. A national average increase can improve overall funding without making every local plan equally viable.
A company’s financial rationale does not reduce the disruption for its members. Once a plan ends, households need to examine the details that determine whether a replacement actually works in daily life.
What Consumers Need to Compare
The annual Medicare Open Enrollment Period runs from October 15 through December 7. CMS urges beneficiaries to review their plan because costs, covered services, provider networks, and pharmacy networks can change from year to year. The agency’s open-enrollment resources direct consumers to compare their available choices before coverage begins on January 1.
For someone whose plan is ending, the first check should be doctors and hospitals. Many Medicare Advantage plans use provider networks, so a physician who accepted the old plan may not accept the new one. The second check is prescription coverage. Every Part D plan uses its own formulary, or list of covered drugs, and pharmacies may offer different prices depending on whether they are preferred, standard, or out of network.
A consumer reviews prescription medication at a pharmacy.
Consumers should also compare the monthly premium, deductible, maximum out-of-pocket limit, copayments, prior-authorization rules, dental or vision benefits, and the plan’s service area. Medicare’s Plan Compare tool allows users to save their current drugs and pharmacies to compare projected plan costs.
People who need free, individualized help can contact their State Health Insurance Assistance Program, or SHIP. Medicare.gov notes that SHIPs are not connected to an insurance company or health plan. That independence can matter when a person must choose between remaining in private Medicare Advantage coverage and returning to Original Medicare.
Those individual comparisons solve the immediate problem. Repeated plan exits, however, also raise a broader policy question: does the payment system give seniors enough stability to make long-term coverage decisions with confidence?
What Policymakers Should Watch
Medicare Advantage is designed to give beneficiaries a private-plan alternative to Original Medicare. Choice can help when plans compete on provider networks, service, drug coverage, and benefits. Choice becomes less meaningful when people must frequently replace a plan they selected because its insurer exits the market.
Lawmakers and CMS should measure more than enrollment totals. They should examine whether plans remain available in rural and urban communities, whether network changes interrupt care, whether formularies preserve access to needed drugs, and whether people receive clear information early enough to compare alternatives.
The policy trade-off is real. Medicare must protect taxpayers and avoid paying private plans more than necessary. At the same time, payment rules that leave insurers unable to sustain plans can shift costs and administrative burdens onto seniors who must navigate another coverage change. The goal is not to guarantee that every private plan lasts forever. It is to make sure consumers have understandable choices and enough time to use them.
Those system-level questions matter because plan stability determines whether consumer choice remains practical when coverage changes.
Wrap Up
Humana’s planned 2027 exits may affect about 600,000 members, but a nonrenewal does not end Medicare eligibility. Affected beneficiaries can choose another Medicare Advantage plan or return to Original Medicare, with separate consideration for prescription-drug coverage.
The practical stakes are personal: a different doctor, a different pharmacy, a higher copayment, or a medication that now requires prior authorization. Consumers should compare options during the October 15–December 7 enrollment period rather than assume that a new plan will match their current coverage.
For policymakers, the larger test is stability. Medicare Advantage should give seniors meaningful options, not simply require them to repeat the same complex search whenever an insurer changes its business strategy.